Abstract
Depression and anxiety are highly comorbid with chronic obstructive pulmonary disease (COPD) and are associated with poor treatment adherence, increased rates of physical disability, functional disability, mortality, healthcare costs, and a worsening quality of life. Despite its prevalence, there is a dearth of research on psychological treatments for depressed and/or anxious patients with COPD. This review examines the current evidence for psychological treatments for depression and anxiety in COPD, structured within the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework, in an effort to highlight the current practice and research needs for this important and complex patient population.
Keywords: Ambulatory care, anxiety, chronic obstructive pulmonary disease, depression, primary care, psychotherapy, REAIM
Current Respiratory Medicine Reviews
Title:Depression and Anxiety in Patients with COPD: A Focus on Psychological Treatments in Ambulatory Care Settings
Volume: 8 Issue: 2
Author(s): Joseph Mignogna, Jeffrey A. Cully
Affiliation:
Keywords: Ambulatory care, anxiety, chronic obstructive pulmonary disease, depression, primary care, psychotherapy, REAIM
Abstract: Depression and anxiety are highly comorbid with chronic obstructive pulmonary disease (COPD) and are associated with poor treatment adherence, increased rates of physical disability, functional disability, mortality, healthcare costs, and a worsening quality of life. Despite its prevalence, there is a dearth of research on psychological treatments for depressed and/or anxious patients with COPD. This review examines the current evidence for psychological treatments for depression and anxiety in COPD, structured within the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework, in an effort to highlight the current practice and research needs for this important and complex patient population.
Export Options
About this article
Cite this article as:
Joseph Mignogna, Jeffrey A. Cully , Depression and Anxiety in Patients with COPD: A Focus on Psychological Treatments in Ambulatory Care Settings, Current Respiratory Medicine Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339812799859743
DOI https://dx.doi.org/10.2174/157339812799859743 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
G Protein-Coupled Receptors – Potential Roles in Clinical Pharmacology
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence
Current Drug Safety The p53-Estrogen Receptor Loop in Cancer
Current Molecular Medicine Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Point of Care Cardiac Ultrasound Applications in the Emergency Department and Intensive Care Unit - A Review
Current Cardiology Reviews Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells
Recent Patents on Regenerative Medicine The Potential of Zn(II) N-Alkylpyridylporphyrins for Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Markers of Cardiovascular Damage in Hypertension
Current Pharmaceutical Design Challenges and Solutions in the Development of Genomic Biomarker Panels: A Systematic Phased Approach
Current Genomics Serum Specific Vasopressin-Degrading Activity is Related to Blood Total Cholesterol Levels in Men but not in Women
Medicinal Chemistry Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention
Current Pharmaceutical Design The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimers Disease
Current Alzheimer Research The V-ATPase as a Target for Antifungal Drugs
Current Protein & Peptide Science A Gastroretentive Drug Delivery System of Lisinopril Imbibed on Isabgol- Husk
Current Drug Delivery Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued) Brain-Derived Neurotrophic Factor and Antidepressant Activity
Current Pharmaceutical Design